{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:35:56Z","timestamp":1787020556890,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Macrophage activation syndrome (MAS) is a life-threatening hyperinflammatory syndrome and is caused by a severely dysregulated immune response. It has rarely been associated with neonatal lupus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We present a female neonate with MAS born to a mother who had cutaneous lupus erythematosus with circulating anti-nuclear antibodies (ANA), anti-SSA, anti-SSB and anti-extractable nuclear antigen (anti-ENA) antibodies.<\/jats:p>\n                    <jats:p>Because of neonatal lupus (NLE) with a total atrioventricular block, epicardial pacemaker implantation was required on the sixth day of life. Following surgery she developed non-remitting fever and disseminated erythematous skin lesions. A diagnosis of MAS was made based on these symptoms, with hyperferritinemia, elevated transaminases, hypertriglyceridemia, and a skin biopsy that showed hemophagocytosis. Our patient was treated with steroids for 3 months with good effect. No relapse has occurred.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MAS is a rare complication of neonatal lupus that may be difficult to diagnose, but needs to be treated promptly. In this article, pathogenesis and overlap of MAS and hemophagocytic lymphohistiocytosis (HLH) has been described.<\/jats:p>\n                    <jats:p>Diagnosis of MAS can be difficult. Different diagnostic criteria are used in both diagnosing MAS and HLH. Validated criteria for diagnosis of MAS in other disease than systemic onset JIA have not been validated yet. In NLE, diagnosing MAS is even more difficult, since skin lesions are already common in NLE. We show the potential additional value of skin biopsy in diagnosing MAS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12969-021-00500-w","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T03:48:44Z","timestamp":1613015324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Macrophage activation syndrome in a newborn: report of a case associated with neonatal lupus erythematosus and a summary of the literature"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5505-6728","authenticated-orcid":false,"given":"Veerle","family":"Heijstek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meelad","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel","family":"van der Palen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra Hissink","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"issue":"9","key":"500_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11926-016-0610-z","volume":"18","author":"MS Klein-Gitelman","year":"2016","unstructured":"Klein-Gitelman MS. Neonatal lupus: what we have learned and current approaches to care. Curr Rheumatol Rep. 2016;18(9):60.","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"500_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s12016-017-8653-0","volume":"53","author":"F Vanoni","year":"2017","unstructured":"Vanoni F, Lava SAG, Fossali EF, Cavalli R, Simonetti GD, Bianchetti MG, et al. Neonatal systemic lupus erythematosus syndrome: a comprehensive review. Clin Rev Allergy Immunol. 2017;53(3):469\u201376.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"9","key":"500_CR3","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1001\/archderm.138.9.1208","volume":"138","author":"DS Morrell","year":"2002","unstructured":"Morrell DS, Pepping MA, Scott JP, Esterly NB, Drolet BA. Cutaneous manifestations of hemophagocytic lymphohistiocytosis. Arch Dermatol. 2002;138(9):1208\u201312.","journal-title":"Arch Dermatol"},{"key":"500_CR4","doi-asserted-by":"publisher","unstructured":"Griffin G, Shenoi S, Hughes GC. Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy. Best Pract Res Clin Rheumatol. 2020;34(4):101515. https:\/\/doi.org\/10.1016\/j.berh.2020.101515. Epub 2020 May 7.","DOI":"10.1016\/j.berh.2020.101515"},{"issue":"5","key":"500_CR5","doi-asserted-by":"publisher","first-page":"608","DOI":"10.5021\/ad.2015.27.5.608","volume":"27","author":"HJ Jun","year":"2015","unstructured":"Jun HJ, Kim HO, Lee JY, Park YM. Preceding annular skin lesions in a patient with Hemophagocytic Lymphohistiocytosis. Ann Dermatol. 2015;27(5):608\u201311.","journal-title":"Ann Dermatol"},{"issue":"2","key":"500_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/jp.2014.207","volume":"35","author":"JH Park","year":"2015","unstructured":"Park JH, Kim SH, Kim HJ, Lee SJ, Jeong DC, Kim SY. Macrophage activation syndrome in a newborn infant born to a mother with autoimmune disease. J Perinatol. 2015;35(2):158\u201360.","journal-title":"J Perinatol"},{"issue":"6","key":"500_CR7","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/ped.12723","volume":"57","author":"H Shimozawa","year":"2015","unstructured":"Shimozawa H, Kono Y, Matano M, Suzuki Y, Koike Y, Yada Y, et al. Cytokine profile in two siblings with neonatal lupus erythematosus. Pediatr Int. 2015;57(6):1211\u20134.","journal-title":"Pediatr Int"},{"issue":"7","key":"500_CR8","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/jp.2012.147","volume":"33","author":"Y Suzuki","year":"2013","unstructured":"Suzuki Y, Takahashi N, Yada Y, Koike Y, Matano M, Nishimura H, et al. Hemophagocytic lymphohistiocytosis in a newborn infant born to a mother with Sjogren syndrome antibodies. J Perinatol. 2013;33(7):569\u201371.","journal-title":"J Perinatol"},{"key":"500_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.clim.2019.07.005","volume":"207","author":"M Shimizu","year":"2019","unstructured":"Shimizu M, Kizawa T, Kato R, Suzuki T, Yachie A. Macrophage activation syndrome in neonates born to mothers with adult-onset Still's disease: perinatal effect of maternal IL-18. Clin Immunol. 2019;207:36\u20139.","journal-title":"Clin Immunol"},{"issue":"5","key":"500_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrrheum.2015.179","volume":"12","author":"AA Grom","year":"2016","unstructured":"Grom AA, Horne A, De Benedetti F. Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol. 2016;12(5):259\u201368.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"500_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1136\/archdischild-2016-310772","volume":"102","author":"ES Sen","year":"2017","unstructured":"Sen ES, Steward CG, Ramanan AV. Diagnosing haemophagocytic syndrome. Arch Dis Child. 2017;102(3):279\u201384.","journal-title":"Arch Dis Child"},{"key":"500_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","volume":"10","author":"CB Crayne","year":"2019","unstructured":"Crayne CB, Albeituni S, Nichols KE, Cron RQ. The immunology of macrophage activation syndrome. Front Immunol. 2019;10:119.","journal-title":"Front Immunol"},{"key":"500_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/OARRR.S151013","volume":"10","author":"B Lerkvaleekul","year":"2018","unstructured":"Lerkvaleekul B, Vilaiyuk S. Macrophage activation syndrome: early diagnosis is key. Open Access Rheumatol. 2018;10:117\u201328.","journal-title":"Open Access Rheumatol"},{"issue":"2","key":"500_CR14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331.","journal-title":"Pediatr Blood Cancer"},{"key":"500_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-med-061813-012806","volume":"66","author":"GS Schulert","year":"2015","unstructured":"Schulert GS, Grom AA. Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies. Annu Rev Med. 2015;66:145\u201359.","journal-title":"Annu Rev Med"},{"issue":"1","key":"500_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12969-016-0130-4","volume":"15","author":"C Bracaglia","year":"2017","unstructured":"Bracaglia C, Prencipe G, De Benedetti F. Macrophage activation syndrome: different mechanisms leading to a one clinical syndrome. Pediatr Rheumatol Online J. 2017;15(1):5.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"500_CR17","doi-asserted-by":"publisher","first-page":"532","DOI":"10.5114\/ceji.2014.47741","volume":"39","author":"AM Dabrowska","year":"2014","unstructured":"Dabrowska AM, Slotwinski R. The immune response to surgery and infection. Cent Eur J Immunol. 2014;39(4):532\u20137.","journal-title":"Cent Eur J Immunol"},{"issue":"8","key":"500_CR18","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/OGX.0000000000000208","volume":"70","author":"AE DeNoble","year":"2015","unstructured":"DeNoble AE, Kuller JA, Rhee EJ. Controversies in the Management of Isolated Congenital Atrioventricular Block. Obstet Gynecol Surv. 2015;70(8):518\u201323.","journal-title":"Obstet Gynecol Surv"},{"issue":"1","key":"500_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1182\/blood-2017-11-814244","volume":"132","author":"IK Chinn","year":"2018","unstructured":"Chinn IK, Eckstein OS, Peckham-Gregory EC, Goldberg BR, Forbes LR, Nicholas SK, et al. Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis. Blood. 2018;132(1):89\u2013100.","journal-title":"Blood"},{"issue":"4","key":"500_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/gene.2012.3","volume":"13","author":"A Ravelli","year":"2012","unstructured":"Ravelli A, Grom AA, Behrens EM, Cron RQ. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Genes Immun. 2012;13(4):289\u201398.","journal-title":"Genes Immun"},{"issue":"9","key":"500_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s11926-014-0439-2","volume":"16","author":"M Zhang","year":"2014","unstructured":"Zhang M, Behrens EM, Atkinson TP, Shakoory B, Grom AA, Cron RQ. Genetic defects in cytolysis in macrophage activation syndrome. Curr Rheumatol Rep. 2014;16(9):439.","journal-title":"Curr Rheumatol Rep"},{"issue":"12","key":"500_CR22","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1002\/art.38793","volume":"66","author":"KM Kaufman","year":"2014","unstructured":"Kaufman KM, Linghu B, Szustakowski JD, Husami A, Yang F, Zhang K, et al. Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis. Arthritis Rheumatol. 2014;66(12):3486\u201395.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"500_CR23","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3899\/jrheum.121233","volume":"40","author":"R Strippoli","year":"2013","unstructured":"Strippoli R, Caiello I, De Benedetti F. Reaching the threshold: a multilayer pathogenesis of macrophage activation syndrome. J Rheumatol. 2013;40(6):761\u20137.","journal-title":"J Rheumatol"},{"issue":"9","key":"500_CR24","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/j.1346-8138.2006.00146.x","volume":"33","author":"A Bay","year":"2006","unstructured":"Bay A, Calka O, Akdeniz N, Oner AF, Kirimi E. Newborn infant with hemophagocytic lymphohistiocytosis and generalized skin eruptions. J Dermatol. 2006;33(9):628\u201331.","journal-title":"J Dermatol"},{"issue":"1","key":"500_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.det.2016.07.005","volume":"35","author":"KW Shwin","year":"2017","unstructured":"Shwin KW, Lee CR, Goldbach-Mansky R. Dermatologic manifestations of monogenic autoinflammatory diseases. Dermatol Clin. 2017;35(1):21\u201338.","journal-title":"Dermatol Clin"},{"issue":"8","key":"500_CR26","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1177\/0961203314529467","volume":"23","author":"X Li","year":"2014","unstructured":"Li X, Qu B, Nie Y, Zhu G, Li W, Mu F. Clinical features of macrophage activation syndrome in the adult northern Chinese population. Lupus. 2014;23(8):785\u201392.","journal-title":"Lupus."},{"issue":"7","key":"500_CR27","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1097\/DAD.0000000000000825","volume":"39","author":"A Santos-Arroyo","year":"2017","unstructured":"Santos-Arroyo A, Barrera-Llaurador J, Sanchez JE, Martin-Garcia R, Sanchez JL. Role of skin biopsies in the diagnosis of Hemophagocytic Lymphohistiocytosis. Am J Dermatopathol. 2017;39(7):e86\u2013e9.","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"500_CR28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1191\/0961203302lu171cr","volume":"11","author":"R Cimaz","year":"2002","unstructured":"Cimaz R, Biggioggero M, Catelli L, Muratori S, Cambiaghi S. Ultraviolet light exposure is not a requirement for the development of cutaneous neonatal lupus. Lupus. 2002;11(4):257\u201360.","journal-title":"Lupus."},{"key":"500_CR29","doi-asserted-by":"publisher","unstructured":"Chamseddin B, Marks E, Dominguez A, Wysocki C, Vandergriff T. Refractory macrophage activation syndrome in the setting of adult-onset still disease with hemophagocytic lymphohistiocytosis detected on skin biopsy treated with canakinumab and tacrolimus. J Cutan Pathol. 2019;46(7):528\u201331. https:\/\/doi.org\/10.1111\/cup.13466. Epub 2019 Apr 23.","DOI":"10.1111\/cup.13466"},{"issue":"7","key":"500_CR30","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/DAD.0000000000000166","volume":"37","author":"K Kerl","year":"2015","unstructured":"Kerl K, Wolf IH, Cerroni L, Wolf P, French LE, Kerl H. Hemophagocytosis in cutaneous autoimmune disease. Am J Dermatopathol. 2015;37(7):539\u201343.","journal-title":"Am J Dermatopathol"},{"issue":"9","key":"500_CR31","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1586\/1744666X.2015.1058159","volume":"11","author":"RQ Cron","year":"2015","unstructured":"Cron RQ, Davi S, Minoia F, Ravelli A. Clinical features and correct diagnosis of macrophage activation syndrome. Expert Rev Clin Immunol. 2015;11(9):1043\u201353.","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"500_CR32","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/art.39332","volume":"68","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Davi S, Horne A, Bovis F, Pistorio A, et al. 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European league against rheumatism\/American College of Rheumatology\/Paediatric rheumatology international trials organisation collaborative initiative. Arthritis Rheumatol. 2016;68(3):566\u201376.","journal-title":"Arthritis Rheumatol."},{"issue":"16","key":"500_CR33","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1182\/blood.2019000936","volume":"135","author":"SW Canna","year":"2020","unstructured":"Canna SW, Marsh RA. Pediatric hemophagocytic lymphohistiocytosis. Blood. 2020;135(16):1332\u201343.","journal-title":"Blood."},{"key":"500_CR34","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.3389\/fimmu.2018.02061","volume":"9","author":"AJ Lee","year":"2018","unstructured":"Lee AJ, Ashkar AA. The dual nature of type I and type II interferons. Front Immunol. 2018;9:2061.","journal-title":"Front Immunol"},{"issue":"1","key":"500_CR35","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.1038\/s41598-018-24198-1","volume":"8","author":"YM El-Sherbiny","year":"2018","unstructured":"El-Sherbiny YM, Psarras A, Md Yusof MY, Hensor EMA, Tooze R, Doody G, et al. A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features. Sci Rep. 2018;8(1):5793.","journal-title":"Sci Rep"},{"key":"500_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12969-015-0055-3","volume":"13","author":"V Boom","year":"2015","unstructured":"Boom V, Anton J, Lahdenne P, Quartier P, Ravelli A, Wulffraat NM, et al. Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2015;13:55.","journal-title":"Pediatr Rheumatol Online J"},{"key":"500_CR37","doi-asserted-by":"crossref","unstructured":"Mehta P, Cron RQ, Hartwell J, Manson JJ, Tattersall RS. Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome. Lancet Rheumatol. 2020.","DOI":"10.1016\/S2665-9913(20)30096-5"},{"issue":"19","key":"500_CR38","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMoa1911326","volume":"382","author":"F Locatelli","year":"2020","unstructured":"Locatelli F, Jordan MB, Allen C, Cesaro S, Rizzari C, Rao A, et al. Emapalumab in children with primary Hemophagocytic Lymphohistiocytosis. N Engl J Med. 2020;382(19):1811\u201322.","journal-title":"N Engl J Med"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-021-00500-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12969-021-00500-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-021-00500-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T09:17:29Z","timestamp":1613035049000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-021-00500-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["500"],"URL":"https:\/\/doi.org\/10.1186\/s12969-021-00500-w","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,10]]},"assertion":[{"value":"29 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"See consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}